Michael J. Mack, MD, FACC

Practice and Outcomes of Percutaneous Coronary Intervention in the Community Before Drug-Eluting Stents: A Report from the HCA D

08/01/2008

Salvatore L. Battaglia , MD, BS;

Lynn G. Tarkington , RN;

Edmund R. Becker , PhD;

Steven D. Culler , PhD;

Michael J. Mack , MD, FACC;

Aaron D. Kugelmass , MD;

David J. Cohen , MD, MPH, MSc;

Frank Houser , MD;

April W. Simon , RN, MSN;

Rapid advancements in percutaneous coronary interventional (PCI) techniques have changed the manner in which we treat coronary artery disease.1 Clinical trials have demonstrated the efficacy of coronary stents in preventing abrupt vessel...

Rapid advancements in...

08/01/2008

Journal of Invasive Cardiology

The Influence of Diabetes Mellitus on the Practice and Outcomes of Percutaneous Coronary Intervention in the Community: A Report

08/01/2008

Aaron D. Kugelmass , MD;

David J. Cohen , MD, MPH, MSc;

Frank Houser , MD;

April W. Simon , RN, MSN;

Salvatore L. Battaglia , MD, BS;

Lynn G. Tarkington , RN;

Michael J. Mack , MD, FACC;

Edmund R. Becker , PhD;

Steven D. Culler , PhD;

Diabetic patients with coronary artery disease (CAD) have poorer long-term prognosis with more revascularization procedures than non-diabetic patients regardless of the initial treatment strategy.1,2 The role of percutaneous versus surgical...

Diabetic patients with coronary...

08/01/2008

Journal of Invasive Cardiology

The MitraClip COAPT Trial and the Status of Transcatheter Mitral Valve Repair

03/27/2014

Michael J. Mack , MD, FACC;

In the United States, the FDA has approved a trial called the COAPT trial, where patients with functional mitral regurgitation are optimized on medical therapy, and then randomized between continuing medical therapy and the MitraClip device.

In the United States, the FDA...

03/27/2014

Cath Lab Digest

Original Contribution

Clinical Relevance of Baseline TCP in Transcatheter Aortic Valve Replacement

09/30/2017

Michael J. Mack , MD, FACC;

Molly Szerlip , MD, FACP;

Anna Sannino , MD;

Robert C. Stoler , MD;

Robert F. Hebeler Jr., MD;

Paul A. Grayburn , MD;

The aim of this study is to investigate the influence of baseline thrombocytopenia (TCP) on short-term and long-term outcomes after TAVR. This study on 732 consecutive patients indicated that baseline TCP is a strong predictor of mortality.

The aim of this study is to...

09/30/2017

Journal of Invasive Cardiology